Then there was the gut feeling: Given that individual investors are the last to know, I also think that the stock would have behaved very differently if the trials had been proceeding favorably.
Thinking about what kinds of things might have influenced PARS' behavior if Dex had been having a positive effect... The obvious example would have been if doctors were seeing unexpected positive recovery outcomes.
What other scenarios could cause a stock's behavior to accurately reflect a double blind trial's progress?... Aiming4.